A S Worobec - JoVE Visualize

Showing results (11-20 of 14) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 14 results.

Experimental Hematology|March 21, 1998

Inhibition of human mast cell growth and differentiation by interferon gamma-1bA S Kirshenbaum, A S Worobec, T A Davis, et al.

Blood|August 15, 2000

Soluble stem cell factor receptor (CD117) and IL-2 receptor alpha chain (CD25) levels in the plasma of patients with mastocytosis: relationships to disease severity and bone marrow pathologyC Akin, L B Schwartz, T Kitoh, et al.

The Journal of Clinical Investigation|December 1, 1995

The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosisL B Schwartz, K Sakai, T R Bradford, et al.

Proceedings of the National Academy of Sciences of the United States of America|November 7, 1995

Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorderH Nagata, A S Worobec, C K Oh, et al.

Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 14 results.

Experimental Hematology|March 21, 1998

Inhibition of human mast cell growth and differentiation by interferon gamma-1bA S Kirshenbaum, A S Worobec, T A Davis, et al.

Blood|August 15, 2000

Soluble stem cell factor receptor (CD117) and IL-2 receptor alpha chain (CD25) levels in the plasma of patients with mastocytosis: relationships to disease severity and bone marrow pathologyC Akin, L B Schwartz, T Kitoh, et al.

The Journal of Clinical Investigation|December 1, 1995

The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosisL B Schwartz, K Sakai, T R Bradford, et al.

Proceedings of the National Academy of Sciences of the United States of America|November 7, 1995

Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorderH Nagata, A S Worobec, C K Oh, et al.

Pageof 2